FengHe Fund Management Pte. Ltd. Acquires Shares of 1,180,848 Astera Labs, Inc. $ALAB

Key Points

• FengHe Fund Management acquired 1,180,848 shares of Astera Labs, Inc., valued at approximately $106.77 million, making it the firm's largest holding at 17.5% of its portfolio.
• Astera Labs reported a 149.5% year-over-year increase in revenue for the last quarter, posting earnings of $0.44 per share, exceeding analysts' estimates.
• Multiple research analysts have recently raised their price targets for Astera Labs, with ranges between $125.00 and $215.00, indicating positive momentum and ratings for the stock.

FengHe Fund Management Pte. Ltd. purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,180,848 shares of the company's stock, valued at approximately $106,772,000. Astera Labs accounts for approximately 17.5% of FengHe Fund Management Pte. Ltd.'s portfolio, making the stock its biggest holding. FengHe Fund Management Pte. Ltd. owned 0.72% of Astera Labs as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ALAB. Oliver Lagore Vanvalin Investment Group acquired a new position in shares of Astera Labs during the 2nd quarter valued at about $29,000. Sound Income Strategies LLC lifted its stake in shares of Astera Labs by 34.7% in the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock valued at $47,000 after purchasing an additional 204 shares during the last quarter. GAMMA Investing LLC lifted its position in Astera Labs by 55.7% in the first quarter. GAMMA Investing LLC now owns 794 shares of the company's stock valued at $47,000 after buying an additional 284 shares during the last quarter. Harbour Investments Inc. lifted its position in Astera Labs by 351.7% in the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock valued at $47,000 after buying an additional 619 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. acquired a new position in Astera Labs in the first quarter valued at about $48,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $194.50 on Thursday. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The firm has a market capitalization of $32.33 billion, a PE ratio of 347.32, a price-to-earnings-growth ratio of 4.97 and a beta of 1.43. The stock's 50-day simple moving average is $186.50 and its 200-day simple moving average is $117.29.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The company had revenue of $191.93 million for the quarter, compared to analysts' expectations of $172.46 million. During the same quarter last year, the company earned $0.13 earnings per share. The firm's revenue for the quarter was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, sell-side analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on ALAB shares. Susquehanna upped their price target on Astera Labs from $80.00 to $125.00 and gave the stock a "neutral" rating in a research note on Thursday, August 7th. Evercore ISI increased their target price on Astera Labs from $104.00 to $215.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 6th. Morgan Stanley increased their price target on shares of Astera Labs from $155.00 to $200.00 and gave the stock an "overweight" rating in a research report on Friday, August 29th. TD Cowen initiated coverage on shares of Astera Labs in a report on Wednesday. They set a "hold" rating and a $200.00 target price on the stock. Finally, Jefferies Financial Group increased their price objective on Astera Labs from $95.00 to $130.00 and gave the company a "buy" rating in a research note on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $155.71.

Insider Activity

In other Astera Labs news, COO Sanjay Gajendra sold 91,441 shares of Astera Labs stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the transaction, the chief operating officer owned 2,170,877 shares of the company's stock, valued at $398,377,638.27. The trade was a 4.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Jitendra Mohan sold 91,441 shares of Astera Labs stock in a transaction on Monday, August 18th. The shares were sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the transaction, the chief executive officer directly owned 2,170,877 shares in the company, valued at $398,377,638.27. The trade was a 4.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,482,036 shares of company stock worth $230,685,952 over the last three months. Company insiders own 12.50% of the company's stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.